Take Control of Your Hereditary Cancer Risk with SDHD Gene Testing
When cancer runs in your family, the uncertainty can feel overwhelming. You might worry about every unusual symptom or wonder if your children will face the same health challenges. Our SDHD Gene Pheochromocytoma Type 1 NGS Genetic DNA Test provides the answers you deserve – giving you the power to make informed decisions about your health future.
Understanding Your SDHD Gene Test
The SDHD gene plays a crucial role in preventing tumour formation in your adrenal glands. When this gene contains specific mutations, it can lead to pheochromocytoma – rare tumours that produce excess hormones causing dangerous blood pressure spikes. Our advanced Next Generation Sequencing (NGS) technology examines your SDHD gene with exceptional accuracy, identifying even the smallest genetic variations that could impact your health.
This isn’t just another test – it’s a comprehensive health assessment that includes genetic counselling to understand your complete family history, ensuring we provide the most relevant and personalised insights for your situation.
Who Should Consider This Genetic Test?
This test could be right for you if:
- You have a family history of pheochromocytoma or paraganglioma tumours
- You experience unexplained episodes of high blood pressure, rapid heartbeat, or excessive sweating
- Multiple family members have been diagnosed with adrenal gland tumours
- You’re planning a family and want to understand potential genetic risks
- You’ve been diagnosed with pheochromocytoma and want genetic confirmation
Many South Africans discover their genetic risks only after experiencing symptoms. Our test helps you stay ahead of potential health issues.
Why Early Detection Matters for Your Health
Knowing your genetic status provides powerful advantages:
- Peace of Mind: Eliminate the uncertainty about your hereditary cancer risk
- Proactive Health Management: Work with your doctor to implement early monitoring if needed
- Family Planning Confidence: Make informed decisions about starting a family
- Preventative Care: Early detection can lead to more effective treatment options
- Reduced Anxiety: Replace worry with knowledge and a clear health plan
Understanding Your Test Results
We know waiting for genetic results can create anxiety. That’s why we provide clear, compassionate explanations of your findings:
- Positive Result: We’ll connect you with specialist oncologists and create a personalised monitoring plan
- Negative Result: Celebrate the reassurance and reduced cancer risk concerns
- Uncertain Variant: Our genetic counsellors will explain what this means and next steps
No matter your results, you’ll receive ongoing support and guidance from our healthcare team.
Transparent Pricing – Exceptional Value
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| SDHD Gene Pheochromocytoma DNA Test | ZAR 9,350 | ZAR 6,700 | ZAR 2,650 |
| Includes genetic counselling session and comprehensive results interpretation | |||
Consider this investment in your health: early detection could prevent costly emergency treatments and provide priceless peace of mind for you and your family.
Why South Africans Trust Oracle Genomics
- Nationwide Coverage: Convenient testing available in Johannesburg, Cape Town, Durban, Pretoria and throughout South Africa
- Medical Expertise: Our tests are developed and interpreted by specialist oncologists
- Advanced Technology: We use cutting-edge NGS technology for maximum accuracy
- Genetic Counselling: Every test includes professional genetic counselling support
- Rapid Turnaround: Receive your results within 3-4 weeks
- Multiple Sample Options: Choose from blood draw, extracted DNA, or simple finger-prick blood spot
Take the First Step Toward Genetic Clarity
Don’t let uncertainty about hereditary cancer risk control your life. Our compassionate team is ready to guide you through this important health journey.
Limited Time Offer: Secure your special pricing of ZAR 6,700 before this opportunity ends. Your health future deserves this investment.
